AI Article Synopsis
- The 2018 heart allocation policy aimed to enhance risk assessment and minimize waitlist deaths for critically ill patients awaiting transplants.
- A study analyzing wait times from 2018 to 2022 found no significant changes in the median wait time for the highest priority patients (status 1), while wait times for status 2 patients increased by an average of 4.2 days with each subsequent period after the policy change.
- Blood type O candidates experienced the longest wait times, and despite regional variations, wait times rose across all regions during the study period.
Article Abstract
The 2018 heart allocation policy sought to improve risk stratification and reduce waitlist mortality for the sickest patients. This study sought to evaluate changes in wait times for the highest priority patients since policy implementation. All adult single-organ transplant recipients were identified in the United Network for Organ Sharing registry from October 18, 2018, to July 8, 2022, and separated into 4 periods. Outcomes were compared by blood type and UNOS region. Over the study period, 897 of 9,143 patients were listed as status 1 with no significant change in median wait time by blood type or region. More patients were listed as status 2 (4,523/9,143), and each subsequent period postpolicy change was associated with a 4.2-day increase in mean status 2 waitlist time (95% confidence interval 3.0-5.5, p < 0.0001). Wait times were longest for candidates with blood type O and shortest for AB & A. Regional variations continued, however, wait time increased in every region over time.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healun.2023.07.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!